Related Experiment Video
Updated: Sep 1, 2025

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Phenotypic and genetic classification of diabetes
Aaron J Deutsch1,2,3,4, Emma Ahlqvist5, Miriam S Udler6,7,8,9
1Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Traditional diabetes classifications (type 1 and type 2) fail to capture patient diversity. Data-driven approaches using clinical and genetic information offer refined subtypes, but implementation challenges remain for clinical practice.
Area of Science:
- Endocrinology and Metabolism
- Genetics and Genomics
- Clinical Medicine
Background:
- The binary classification of diabetes mellitus into type 1 and type 2 is insufficient to address the condition's heterogeneity.
- Patient variability in presentation, disease progression, treatment response, and complication development necessitates a more nuanced approach.
Purpose of the Study:
- To review data-driven strategies for refining diabetes mellitus subclassification.
- To explore the integration of clinical phenotypes and genetic data for improved patient stratification.
- To assess the benefits, limitations, and practical implementation barriers of proposed subclassification schemas.
Main Methods:
- Literature review of studies employing data-driven approaches for diabetes subtyping.
- Analysis of methodologies utilizing clinical characteristics and/or genetic markers.
- Evaluation of proposed subclassification frameworks based on empirical data.
Main Results:
- Several data-driven subclassification models have been proposed, moving beyond the traditional type 1 and type 2 dichotomy.
- These refined subtypes demonstrate potential for better prediction of disease course and therapeutic response.
- Significant challenges exist in translating these research findings into routine clinical practice.
Conclusions:
- Current diabetes classification systems require enhancement to account for significant patient heterogeneity.
- Data-driven approaches integrating clinical and genetic data show promise for more precise diabetes management.
- Overcoming practical and logistical barriers is crucial for the clinical adoption of refined diabetes subtypes.
More Related Videos
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Genetic Lingo

